Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Oral Dis ; 29(3): 990-995, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-34773326

RESUMO

Radiation therapy is a critical strategy for the treatment of malignant tumors. X-ray external radiation has been successfully used to treat head and neck cancer. On the other hand, 131 I internal radiation has been effective in managing differentiated thyroid cancer. However, these therapies cause radiation damage to salivary glands. Radiation sialadenitis is the most common complication associated with radiotherapy applied to the head and neck and it severely affects patients' quality of life. Since DNA is the main intracellular target of radiation, and the integrity of the DNA structure is critical to genomic stability and the cellular survival of salivary glands, regulating radiation-induced DNA damage offers great promise in preventing and managing radiation sialadenitis. In this review, we summarize recent progress in DNA damage and repair in irradiated salivary glands.


Assuntos
Sialadenite , Neoplasias da Glândula Tireoide , Humanos , Qualidade de Vida , Sialadenite/genética , Sialadenite/radioterapia , Glândulas Salivares/fisiologia , Dano ao DNA , Neoplasias da Glândula Tireoide/genética , Neoplasias da Glândula Tireoide/radioterapia , Neoplasias da Glândula Tireoide/complicações , Radioisótopos do Iodo
2.
PLoS One ; 12(1): e0169443, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28099448

RESUMO

Diabetes can lead to dysfunction of the secretory capacity in salivary glands. Activation of the receptor for advanced glycation end products (RAGE) and its ligands has been suggested to participate in chronic disorders such as diabetes and its complications. In this study, the expression of RAGE, high mobility group box 1 (HMGB1) and advanced glycation end products (AGE), as well as the effects of low-power laser irradiation (LPLI) in salivary glands of diabetic rats were evaluated, and the mechanisms involved were characterized. The expression of RAGE and HMGB1 at the protein and mRNA levels was observed in submandibular glands (SMGs) of streptozotocin-induced diabetic rats. A diode laser was applied at 660 nm, 70 mW, 20 J/cm2, 0.56 J/point, with a spot area of 0.028 cm2 and its in vivo effects and the pathways involved were evaluated. Immunohistochemistry and western blotting analysis were performed for inflammatory and apoptosis markers. Diabetes up-regulates HMGB1/AGE/RAGE axis gene expression in SMGs that is associated with activation of the nuclear factor kappa B (NF-κB) pathway. Interestingly, LPLI suppresses NF-κB activation induced by inflammation. LPLI also reduces diabetes-induced apoptosis. That effect was accompanied by decreased levels of Bax, and cleaved caspase 3, which were up-regulated in diabetes. Taken together, our data suggest that LPLI reduces diabetes-induced inflammation by reducing the induction of HMGB1, ultimately leading to inhibition of apoptosis in submandibular glands of diabetic rats.


Assuntos
Diabetes Mellitus Experimental/complicações , Sialadenite/radioterapia , Glândula Submandibular/efeitos da radiação , Animais , Apoptose/efeitos da radiação , Diabetes Mellitus Experimental/patologia , Feminino , Produtos Finais de Glicação Avançada/metabolismo , Proteína HMGB1/metabolismo , Terapia com Luz de Baixa Intensidade , Ratos , Ratos Wistar , Receptor para Produtos Finais de Glicação Avançada/metabolismo , Sialadenite/metabolismo , Sialadenite/patologia , Glândula Submandibular/patologia
3.
Stomatologiia (Mosk) ; 72(4): 32-6, 1993.
Artigo em Russo | MEDLINE | ID: mdl-8108818

RESUMO

Basing on analysis of clinical cases, the authors make suggestions on clinical and laboratory examinations and comprehensive pathogenetic therapy of patients with acute and chronic nonspecific inflammation of the salivary glands making use of low-energy He-Ne laser. Good results were attained in 95% of patients. The most marked effect of comprehensive treatment was observed when 5 min laser exposure at irradiation power of 0.8 to 1.3 mWt/cm2 was used.


Assuntos
Terapia a Laser , Sialadenite/radioterapia , Adulto , Idoso , Velocidade do Fluxo Sanguíneo/efeitos da radiação , Volume Sanguíneo/efeitos da radiação , Doença Crônica , Humanos , Pessoa de Meia-Idade , Dosagem Radioterapêutica , Indução de Remissão , Sialadenite/fisiopatologia , Fatores de Tempo , Xerostomia/fisiopatologia , Xerostomia/radioterapia
4.
Stomatologiia (Mosk) ; 68(2): 35-6, 1989.
Artigo em Russo | MEDLINE | ID: mdl-2749817

RESUMO

A novel technique is offered for treatment of sialadenitis. Ultraviolet irradiation conductors are inserted into the gland via its major duct for subsequent intracorporeal UV therapy of the gland. The results of the treatment are analyzed in 57 cases of sialadenitis observed during 1 to 2.5 years. The technique proved effective enough to be recommended for practical application.


Assuntos
Braquiterapia/métodos , Doenças das Glândulas Salivares/radioterapia , Sialadenite/radioterapia , Terapia Ultravioleta/métodos , Braquiterapia/instrumentação , Estudos de Avaliação como Assunto , Seguimentos , Humanos , Síndrome de Sjogren/radioterapia , Terapia Ultravioleta/instrumentação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA